Skip to main content

Day: March 2, 2020

myBeazley e-trading broker platform for small and medium-sized business to make Beazley’s market-leading cyber coverage faster and easier to access

New York, March 02, 2020 (GLOBE NEWSWIRE) — Beazley announced today that its flagship cyber product, Beazley Breach Response (BBR), will be available to brokers of small and medium-sized business through the myBeazley platform in the US, reducing to less than two minutes the time required to obtain a bindable BBR quote.The platform has been designed to meet the needs of brokers bringing small and medium-sized business accounts with revenues of less than $100m to Beazley. Once quoted, brokers can access accounts, update information and bind policies with just a few clicks.At each stage in the placement process, myBeazley makes the broker’s task simpler, including by paring to the minimum the questions in the online form required to obtain a quote. The form has 13 fields but six of these will normally be prefilled automatically. The...

Continue reading

Eezy Plc: Invitation to briefing on the 2019 Financial statements bulletin

EEZY PLC  —  INVESTOR NEWS  —  2 MARCH 2020 AT 15:30Eezy Plc: Invitation to briefing on the 2019 Financial statements bulletin  Eezy Plc will publish the Financial statements bulletin for year 2019 on Thursday 5 March 2020 approx. at 8.00.A Finnish-language briefing for investors, analysts and media will be held on 5 March 2020 at 12.00 a.m. Finnish time in Restaurant Salutorget, Pohjoisesplanadi 15, Helsinki, and streamed as a webcast at  https://eezy.videosync.fi/tulosjulkistus-2019The conference will be hosted by CEO Sami Asikainen and CFO Hannu Nyman. During the presentation, there will be an opportunity to ask questions.A recording of the webcast will be available at the company’s website later on the same day. Further information:Hannu NymanCFOEezy Plchannu.nyman@eezy.fitel. +358 (0)50 306 9913

Continue reading

Kutsu Eezy Oyj:n tilinpäätöstiedotteen 2019 tiedotustilaisuuteen

EEZY OYJ  —  SIJOITTAJAUUTINEN  —  2.3.2020 KLO 15.30Kutsu Eezy Oyj:n tilinpäätöstiedotteen 2019 tiedotustilaisuuteenEezy Oyj julkistaa tilinpäätöstiedotteen vuodelta 2019 torstaina 5.3.2020 noin klo 8.00.Suomenkielinen tiedotustilaisuus sijoittajille, analyytikoille ja medialle järjestetään 5.3.2020 klo 12.00 Ravintola Salutorgetissa, Pohjoisesplanadi 15, Helsinki, ja on nähtävissä webcast-lähetyksenä osoitteessa  https://eezy.videosync.fi/tulosjulkistus-2019 Tilaisuutta isännöivät toimitusjohtaja Sami Asikainen ja talousjohtaja Hannu Nyman. Tilaisuuden aikana voit esittää kysymyksiä verkon välityksellä.Tilaisuuden nauhoitus on saatavilla yhtiön verkkosivuilta myöhemmin päivän aikana.Lisätietoja:Hannu NymantalousjohtajaEezy Oyjhannu.nyman@eezy.fipuh. +358 (0)50 306 9913

Continue reading

US Nuclear: The Brain Machine Interface Will Change The World

Chapter 1: Prostheses and Artificial Arms and LegsLOS ANGELES, CA, March 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – US Nuclear Corp. (OTC: UCLE) recently acquired a 40% stake in Grapheton Inc, and in doing so, joined the future of the brain-machine interface revolution. The first chapter in this new journey is the use of prostheses, or artificial body parts, such as a leg or arm.  Due to accidents, wars, diabetes, and other causes, over 275 million Americans have lost a limb.  Additionally, many more people still have their limbs, but have lost their ability to use them due to mishaps, spinal injuries, and stroke.   Cutting edge technology from Grapheton and other pioneers in this field will allow these prostheses to be truly functional and widely available.  Grapheton alone has made several patented advancements, including:...

Continue reading

BridgeBio Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Portfolio Progress

-Achieved multiple clinical and pre-clinical milestones across BridgeBio’s pipeline-Delivered pipeline expansion with addition of five new drug development and discovery programs; BridgeBio’s portfolio now includes more than 20 potential medicinesSAN FRANCISCO, March 02, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (NASDAQ: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today is reporting its fourth quarter and full year 2019 financial results and recent progress across its portfolio, which now includes more than 20 drug development and discovery programs.2019 was a year of significant growth and milestone achievements for BridgeBio. The company initiated its first New Drug Application (NDA) with the United States Food and Drug Administration (FDA) and added five new drug development and discovery...

Continue reading

Arion Bank hf. covered bond offering on 4 March 2020

Arion Bank will be offering ISK denominated covered bonds series ARION CB 24 and ARION CBI 26 on 5 February 2020. The bonds are expected to be listed on Nasdaq Iceland on 11 March 2020.The offering will be managed by Arion Bank fixed income sales. All offers shall be submitted by email to midlun@arionbanki.is before 16:00 on 4 March 2020.For further information please contact Investor relations, at ir@arionbanki.is 

Continue reading

Arion Banki: Útboð sértryggðra skuldabréfa þann 4. mars 2020

Arion banki verður með útboð á sértryggðu skuldabréfaflokkunum ARION CB 24 og ARION CBI 26 þann 4 mars næstkomandi.Stefnt er að töku skudlabréfanna til viðskipta á Nasdaq Iceland þann 11 mars 2020.Verðbréfamiðlun Arion banka hefur umsjón með útboðinu. Tilboðum skal skilað á tölvupóstfangið miðlun@arionbanki.is fyrir kl 16:00 þann 4 mars 2020.Nánari upplýsingar veitir Theódór Friðbertsson, fjárfestatengslum Arion banka, theodor.fridbertsson@arionbanki.is, s. 444 6760 

Continue reading

Inspirage Acquires Vertical Edge Consulting Group

BELLEVUE, Wash., March 02, 2020 (GLOBE NEWSWIRE) — Inspirage, an award-winning provider of Oracle Enterprise Resource Planning (ERP), Product Lifecycle Management, Supply Chain Management and Logistics Management implementation services announced today that they have completed their acquisition of Vertical Edge Consulting Group, a leading full-service Oracle Enterprise Performance Management (EPM) and Business Intelligence(BI) consulting firm. Financial terms of the transaction were not disclosed.With this acquisition, Inspirage strengthens their ability to help companies implement a full suite of Oracle ERP Cloud applications. Leading industry analyst firms, such as Gartner,  consider Inspirage to be a leader in the Cloud application marketplace based on the ability to execute and completeness of vision. This acquisition further...

Continue reading

Novo Agrees to Acquire Significant Stake in New Found Gold Corp.

VANCOUVER, British Columbia, March 02, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has subscribed for 15,000,000 common shares of New Found Gold Corp. (“New Found”), a Canadian private exploration company with the largest mineral claim package in the Province of Newfoundland and Labrador. The subscription price will be paid by the issuance of 6,944,444 common shares of Novo (the “Acquisition”). The Acquisition is subject to TSX Venture Exchange approval.Upon closing of the Acquisition and assuming no further share issuances by New Found or Novo, Novo will own approximately 15.97% of the issued and outstanding shares of New Found and New Found will own approximately 3.73% of the issued and outstanding common shares of Novo. The Acquisition gives...

Continue reading

Ascom Myco 3 smartphone gets certification from MEDITECH for the Expanse Point of Care EHR Solution

Ascom announced that EHR provider MEDITECH has certified the Ascom Myco 3 smartphone with its Expanse Point of Care solution. Nurses, therapists, aides, and other clinicians can now complete most tasks on their handheld Ascom Myco 3 device – including receive alerts, document vitals and interventions, review records, and verify and administer medications using the smartphone’s built-in barcode scanner. Patients can also benefit from more quality caregiving time with their clinicians.MEDITECH joins an increasing roster of prominent EHR companies to certify the healthcare device on its platform to meet the communication needs of medical organizations today and tomorrow.Pamela Crandall, Senior Marketing Solution Manager at MEDITECH, says: “The Ascom Myco 3 device gives our customers another powerful option for accessing our Expanse Point of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.